Literature DB >> 23206765

Temporal ordering of interstitial cystitis/bladder pain syndrome and non-bladder conditions.

J Quentin Clemens1, Marc N Elliott, Marika Suttorp, Sandra H Berry.   

Abstract

OBJECTIVE: To examine the prevalence and timing of nonbladder conditions in a community cohort of women with symptoms of interstitial cystitis/bladder pain syndrome (IC/BPS).
METHODS: As part of the Rand Interstitial Cystitis Epidemiology (RICE) study, we identified 3397 community women who met a validated case definition for IC/BPS symptoms. Each completed a survey asking if they had a physician diagnose them as having irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, migraines, panic attacks, or depression. If a positive response was received, subjects were asked to provide the age of symptom onset. All subjects were also asked to provide the date of IC/BPS symptom onset.
RESULTS: A total of 2185 women reported a diagnosis of at least one of the nonbladder conditions. Onset of bladder symptoms was not consistently earlier or later than the onset of nonbladder symptoms. Depression tended to occur earlier (P < .05), whereas fibromyalgia generally occurred later (P < .05). Mean age of onset was lowest for migraine symptoms, depression symptoms, and panic attacks symptoms, and greatest for fibromyalgia and chronic fatigue syndrome symptoms. Mean age of irritable bowel syndrome and IC/BPS symptom onset was between these other conditions.
CONCLUSION: These findings confirm the common co-occurrence of IC/BPS with chronic nonbladder conditions. In women with IC/BPS symptoms and coexistent nonbladder conditions, bladder symptoms do not uniformly predate the nonbladder symptoms. These observations suggest that phenotypic progression from isolated bladder symptoms to regional/systemic symptoms is not a predominant pattern in IC/BPS, although such a pattern may occur in a subset of individuals.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23206765      PMCID: PMC3804419          DOI: 10.1016/j.urology.2012.06.059

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  22 in total

1.  Risk of irritable bowel syndrome and depression in women with interstitial cystitis: a case-control study.

Authors:  Joseph M Novi; Stacey Jeronis; Sindhu Srinivas; Radhika Srinivasan; Mark A Morgan; Lily A Arya
Journal:  J Urol       Date:  2005-09       Impact factor: 7.450

2.  Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes.

Authors:  M Alagiri; S Chottiner; V Ratner; D Slade; P M Hanno
Journal:  Urology       Date:  1997-05       Impact factor: 2.649

Review 3.  Corticotropin releasing factor: a mediator of emotional influences on bladder function.

Authors:  Adam P Klausner; William D Steers
Journal:  J Urol       Date:  2004-12       Impact factor: 7.450

4.  Female, but not male, serotonin reuptake transporter (5-HTT) knockout mice exhibit bladder instability.

Authors:  L L Cornelissen; D P Brooks; A Wibberley
Journal:  Auton Neurosci       Date:  2005-07-14       Impact factor: 3.145

5.  Agreement between questionnaire data and medical records of chronic diseases in middle-aged and elderly Finnish men and women.

Authors:  N Haapanen; S Miilunpalo; M Pasanen; P Oja; I Vuori
Journal:  Am J Epidemiol       Date:  1997-04-15       Impact factor: 4.897

6.  Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome.

Authors:  John W Warren; Fred M Howard; Raymond K Cross; Janine L Good; Myrna M Weissman; Ursula Wesselmann; Patricia Langenberg; Patty Greenberg; Daniel J Clauw
Journal:  Urology       Date:  2008-11-08       Impact factor: 2.649

7.  Case-control study of medical comorbidities in women with interstitial cystitis.

Authors:  J Quentin Clemens; Richard T Meenan; Maureen C O'Keeffe Rosetti; Teresa A Kimes; Elizabeth A Calhoun
Journal:  J Urol       Date:  2008-04-18       Impact factor: 7.450

8.  Predictors of symptom severity in patients with chronic prostatitis and interstitial cystitis.

Authors:  J Quentin Clemens; Sheila O Brown; Lara Kozloff; Elizabeth A Calhoun
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

Review 9.  Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine.

Authors:  K B Thor; M Kirby; L Viktrup
Journal:  Int J Clin Pract       Date:  2007-06-30       Impact factor: 2.503

Review 10.  Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome.

Authors:  Mira Meeus; Jo Nijs
Journal:  Clin Rheumatol       Date:  2006-11-18       Impact factor: 2.980

View more
  18 in total

Review 1.  Does central sensitization help explain idiopathic overactive bladder?

Authors:  W Stuart Reynolds; Roger Dmochowski; Alan Wein; Stephen Bruehl
Journal:  Nat Rev Urol       Date:  2016-06-01       Impact factor: 14.432

2.  Autonomic neurophysiologic implications of disorders comorbid with bladder pain syndrome vs myofascial pelvic pain.

Authors:  Gisela G Chelimsky; Sheng Yang; Tatiana Sanses; Curtis Tatsuoka; C A Tony Buffington; Jeffrey Janata; Patrick McCabe; Mary-Alice Dombroski; Sarah Ialacci; Adonis Hijaz; Sangeeta Mahajan; Denniz Zolnoun; Thomas C Chelimsky
Journal:  Neurourol Urodyn       Date:  2019-04-04       Impact factor: 2.696

3.  Relationship between chronic nonurological associated somatic syndromes and symptom severity in urological chronic pelvic pain syndromes: baseline evaluation of the MAPP study.

Authors:  John N Krieger; Alisa J Stephens; J Richard Landis; J Quentin Clemens; Karl Kreder; H Henry Lai; Niloofar Afari; Larissa Rodríguez; Anthony Schaeffer; Sean Mackey; Gerald L Andriole; David A Williams
Journal:  J Urol       Date:  2014-10-22       Impact factor: 7.450

4.  Longitudinal Changes in the Pelvic Pain Only and Widespread Pain Phenotypes Over One Year in the MAPP-I Urologic Chronic Pelvic Pain Syndrome (UCPPS) Cohort.

Authors:  Henry Lai; Emine O Bayman; Michael O Bishop; Richard Landis; Steven E Harte; Quentin Clemens; Larissa V Rodriguez; Siobhan Sutcliffe; Bayley J Taple; Bruce D Naliboff
Journal:  Urology       Date:  2022-01-10       Impact factor: 2.633

5.  Symptom Duration in Patients With Urologic Chronic Pelvic Pain Syndrome is not Associated With Pain Severity, Nonurologic Syndromes and Mental Health Symptoms: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Network Study.

Authors:  Larissa V Rodríguez; Alisa J Stephens; J Quentin Clemens; Dedra Buchwald; Claire Yang; Henry H Lai; John N Krieger; Craig Newcomb; Cate S Bradley; Bruce Naliboff
Journal:  Urology       Date:  2018-11-16       Impact factor: 2.649

6.  Pelvic Floor and Urinary Distress in Women with Fibromyalgia.

Authors:  Kim Dupree Jones; Charlene Maxwell; Scott D Mist; Virginia King; Mary Anna Denman; W Thomas Gregory
Journal:  Pain Manag Nurs       Date:  2015-08-08       Impact factor: 1.929

7.  Comparison of Voiding Dysfunction Phenotypes in Women with Interstitial Cystitis/Bladder Pain and Myofascial Pelvic Pain: Results from the ICEPAC Trial.

Authors:  A Petrikovets; I E Veizi; A Hijaz; S T Mahajan; F Daneshgari; C A T Buffington; P McCabe; T Chelimsky
Journal:  Urology       Date:  2019-01-22       Impact factor: 2.649

8.  Comorbidities in a Nationwide, Heterogenous Population of Veterans with Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Bethany F Laden; Catherine Bresee; Amanda De Hoedt; Kai B Dallas; April Scharfenberg; Roopali Saxena; Justin F Senechal; Kamil E Barbour; Jayoung Kim; Stephen J Freedland; Jennifer T Anger
Journal:  Urology       Date:  2021-04-23       Impact factor: 2.649

9.  Autonomic testing of women with interstitial cystitis/bladder pain syndrome.

Authors:  Gisela Chelimsky; N Patrick McCabe; Jeffrey Janata; Robert Elston; Lu Zhang; Sarah Ialacci; Thomas Chelimsky
Journal:  Clin Auton Res       Date:  2014-04-30       Impact factor: 4.435

10.  Common patterns of morbidity and multi-morbidity and their impact on health-related quality of life: evidence from a national survey.

Authors:  R E Mujica-Mota; M Roberts; G Abel; M Elliott; G Lyratzopoulos; M Roland; J Campbell
Journal:  Qual Life Res       Date:  2014-10-26       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.